Neurotransmitter antagonism in management of irritable bowel syndrome
- PMID: 10744083
- DOI: 10.1016/S0140-6736(00)02028-6
Neurotransmitter antagonism in management of irritable bowel syndrome
Comment on
-
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.Lancet. 2000 Mar 25;355(9209):1035-40. doi: 10.1016/S0140-6736(00)02033-X. Lancet. 2000. PMID: 10744088 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
